-transparent.png){kind=logo}
All-trans-retinoic acid (ATRA) was administered at 45 mg/m2 to 4 Japanese patients with acute promyelocytic leukemia (APL). A pharmacokinetic study revealed that the mean peak plasma concentration was 208 ng/ml and was reached at 150 min after ingestion. The mean area under the concentration x time curve (AUC) was 498 ng.h/ml. Two patients showed a good hematological response to ATRA, and they had higher peak plasma concentrations of ATRA and larger AUCs. In one patient, dose escalation of ATRA (90 mg/m2) increased the plasma concentration markedly. In another patient, the plasma concentration decreased markedly in the fasting state. A larger pharmacokinetic study is necessary to examine the influence of food on the absorption of this agent and an optimum administration schedule of ATRA in Japanese APL cases.
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
December 1991,
Leukemia,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
October 2003,
American journal of hematology,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
October 1994,
Seminars in hematology,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
October 2001,
Oncogene,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
January 1991,
Nouvelle revue francaise d'hematologie,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
February 1998,
The New England journal of medicine,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
October 1997,
The New England journal of medicine,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
January 1992,
Leukemia,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
September 2006,
American journal of hematology,
K Usuki, and
M Endo, and
M Osawa, and
K Kitazume, and
S Iki, and
A Urabe
March 1988,
Zhonghua yi xue za zhi,
